In vitro activity of Bay 12-8039, a new 8-methoxyquinolone, compared to the activities of 11 other oral antimicrobial agents against 390 aerobic and anaerobic bacteria isolated from human and animal bite wound skin and soft tissue infections in humans

Antimicrobial Agents and Chemotherapy

Volumn 41, Issue 7, 1997, Pages 1552-1557

  Goldstein, Ellie J C ^a,b,c   Citron, Diane M ^a   Hudspeth, Marie ^a   Gerardo, Sharon Hunt ^a   Merriam, C Vreni ^a  

^a R M ALDEN RESEARCH LABORATORY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 CYCLOPROPYL 7 (2,8 DIAZABICYCLO[4,3,0]NON 8 YL) 6 FLUORO 8 METHOXY 1,4 DIHYDRO 4 OXO 3 QUINOLINE; ANTIINFECTIVE AGENT; AZITHROMYCIN; CEFPODOXIME; CEFUROXIME; CIPROFLOXACIN; CLARITHROMYCIN; DOXYCYCLINE; LEVOFLOXACIN; MOXIFLOXACIN; OFLOXACIN; PENICILLIN G; QUINOLONE DERIVATIVE; SPARFLOXACIN; UNCLASSIFIED DRUG;

ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL FLORA; BITE; BITE WOUND; FUSOBACTERIUM NUCLEATUM; HUMAN; HUMAN TISSUE; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROPHYLAXIS; SKIN INFECTION; SOFT TISSUE INFECTION; WOUND INFECTION;

EID: 0030811984     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.41.7.1552     Document Type: Article

References (35)

1. Aldridge, K. E., and D. S. Ashcraft. 1997. Comparison of the in vitro activities of Bay 12-8039, a new quinolone, and other antimicrobials against clinically important anaerobes. Antimicrob. Agents Chemother. 41:709-711.
2. Alexander, C. J., D. M. Citron, S. H. Gerardo, M. C. Claros, D. Talan, and E. J. C. Goldstein. 1997. Characterization of saccharolytic Bacteroides and Prevotella isolates from infected dog and cat bite wounds in humans. J. Clin. Microbiol. 35:406-411.
3. Appelbaum, P. C., S. K. Spangler, and M. R. Jacobs. 1990. β-Lactamase production and susceptibilities to amoxicillin, amoxicillin-clavulanate, ticarcillin, ticarcillin-clavulanate, cefoxitin, imipenem, and metronidazole of 320 non-Bacteroides fragilis Bacteroides isolates and 129 fusobacteria from 28 U.S. centers. Antimicrob. Agents Chemother. 34:1546-1550.
4. Brook, I. 1987. Microbiology of human and animal bite wounds in children. Pediatr. Infect. Dis. J. 6:29-32.
5. Callaham, M. 1980. Prophylactic antibiotics in common dog bite wounds: a controlled study. Ann. Emerg. Med. 9:410-414.
6. Chin, N. I., J.-W. Gu, K.-W. Yu, Y.-X. Zhang, and H. C. Neu. 1991. In vitro activity of sparfloxacin. Antimicrob. Agents Chemother. 35:567-571.
7. Citron, D. M., M. C. Claros, S. H. Gerardo, F. Abrahamian, D. Talan, and E. J. C. Goldstein. 1996. Frequency of Porphyromonas species from infected dog and cat bite wounds in humans and their characterization by biochemical tests and AP-PCR fingerprinting. Clin. Infect. Dis. 23(Suppl. 1):78-82.
8. Dalhoff, A., U. Petersen, and R. Endermann. 1996. In vitro activity of Bay-12-8039, a new 8-methoxy-quinolonc. Chemotherapy (Basel) 42:410-425.
9. Felmingham, D., M. J. Robbins, A. Leakey, H. Salman, C. Dencer, S. Clark, G. L. Ridgway, and R. N. Gruneberg. 1996. In vitro activity of Bay 12-8039 against bacterial respiratory trac! pathogens, mycoplasmas and obligate anaerobic bacteria, abstr F-8, p. 101. In Program and abstracts of the 36th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
10. Fu, K. P., C. Lafredo, B. Foleno, D. M. Isaaacson, J. F. Barrett, A. J. Tobia, and M. E. Rosenthyale. 1992. In vitro and in vivo antibacterial activities of levofloxacin (l-ofloxacin), an optically active ofloxacin. Antimicrob. Agents Chemother. 36:860-866.
11. Goldstein, E. J. C., P. H. Summanen, D. M. Citron, M. H. Rosove, and S. M. Finegold. 1995. Fatal sepsis due to a beta-lactamase producing strain of a Fusobacterium nucleatum ss polymorphum. Clin. Infect. Dis. 20:797-800.
12. Goldstein, E. J. C. 1991. Bite wounds and infection. Clin. Infect. Dis. 14: 633-640.
13. Goldstein, E. J. C., and D. M. Citron. 1988. Comparative activities of cefuroxime, amoxicillin-clavulanic acid, ciprofloxacin, enoxacin, and ofloxacin against aerobic and anaerobic bacteria isolated from bite wounds. Antimicrob. Agents Chemother. 32:1143-1148.
14. Goldstein, E. J. C., and D. M. Citron. 1993. Comparative susceptibilities of 173 aerobic and anaerobic bite wound isolates to sparfloxacin, temafloxacin, clarithromycin, and older agents. Antimicrob. Agents Chemother. 37:1150-1153.
15. Goldstein, E. J. C., D. M. Citron, B. Wield, U. Blachman, V. L. Sutter, T. A. Miller, and S. M. Finegold. 1978. Bacteriology of human and animal bite wounds. J. Clin. Microbiol. 8:667-672.
16. Goldstein, E. J. C., D. M. Citron, C. Nesbit, M. C. Claros, G. J. Moran, F. M. Abrahamian, D. A. Talan, and the Emergency Medicine Animal Bite Infection Study Group. 1997. Prevalence and characterization of anaerobic bacteria from 50 patients with infected cat and dog bite wounds, p. 427-435. In A. Eley and K. Bennett (ed.), Anaerobic pathogens. Academic Press, Sheffield, United Kingdom.
17. Herrington, J. A., J. A. Federici, B. G. Painter, J. M. Remy, M. I. Barbiero, and B. E. Thurberg. 1996. In vitro activity of Bay 12-8039, a new quinolone, abstr. F-4, p. 100. In Program and abstracts of the 36th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
18. Holdeman, L. V., and W. E. C. Moore. 1977. Anaerobic laboratory manual, 4th ed. Virginia Polytechnic Institute and State University, Blacksburg.
19. Holst, E., J. Rollof, L. Larsson, and J. P. Nielsen. 1992. Characterization and distribution of Pasteurella species recovered from infected humans. J. Clin. Microbiol. 30:2984-2987.
20. Holt, J. G., N. R. Krieg, P. H. A. Smith, J. T. Stanley, and S. T. Williams. 1994. Bergey's manual of determinative bacteriology, 9th ed. The Williams & Wilkins Co., Baltimore, Md.
21. Klien, D. 1966. Friendly dog syndrome. N.Y. State J. Med. 66:2306-2309.
22. Kuzitza, D., H. H. Stass, W. Wingender, and J. Kuhlmann. 1996. Bay 12-8039 (I), a new 8-methoxy-quinolone: safety (S), tolerability (T), and steady state pharmacokinetics (PK) in healthy male volunteers, abstr. F-25, p. 104. In Program and abstracts of the 36th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
23. Murray, P. R., E. J. Baron, M. A. Pfaller, V. C. Tenover, and R. H. Yolken (ed.). 1995. Manual of clinical microbiology, 6th ed. American Society for Microbiology, Washington, D.C.
24. Mutters, R., P. Ihm, S. Pohl, W. Frederiksen, and W. Mannheim. 1985. Reclassification of the genus Pasteurella Trevisan 1887 on the basis of deoxyribonucleic acid homology, with proposals for the new species Pasteurella dagmatis, Pasteurella canis, Pasteurella stomatis, Pasteurella anatis, and Pasteurella langaa. Int. J. Syst. Bacteriol. 35:309-322.
25. National Committee for Clinical Laboratory Standards. 1993. Methods for antimicrobial susceptibility testing of anaerobic bacteria, 3rd ed. Approved standard. NCCLS publication no. M11-A3. National Committee for Clinical Laboratory Standards, Villanova, Pa.
26. National Committee for Clinical Laboratory Standards. 1993. Method for dilution antimicrobial susceptibility testing for bacteria that grow aerobically, 3rd ed. Approved standard. NCCLS publication no. M7-A3. National Committee for Clinical Laboratory Standards, Villanova, Pa.
27. Neu, H. C., and N.-X. Chin. 1989. In vitro activity of S-ofloxacin. Antimicrob. Agents Chemother. 33:1105-1107.
28. Nord, C. E., A. Lindmark, and I. Persson. 1993. In vitro activity of the new quinolone Bay y 3118 against anaerobic bacteria. Eur. J. Clin. Microbiol. Infect. Dis. 12:640-642.
29. Petersen, U., K.-D. Bremm, A. Dalhoff, R. Endermann, W. Heilmann, A. Krebs, and T. Schenke. 1996. Synthesis and in vitro activity of Bay 12-8039, a new 8-methoxy-quinolone, abstr. F-1, p. 100. In Program and abstracts of the 36th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
30. Pouedras, P., P. Y. Donnio, Y. Le Tuzlo, and J. L. Avril. 1993. Pasteurella stomatis infection following a dog bite. Eur. J. Clin Microbiol. Infect Dis. 12:65. (Letter.)
31. Siefert, H. M., A. Domdey-Bette, K. Henninger, F. Hucke, C. Kohlsdorfer, and H. Stass. 1996. Bay 12-8039, a new 8-methoxyquinolone: comparison of the pharmacokinetics in different mammalian species, abstr. F-20, p. 103. In Program and abstracts of the 36th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
32. Summanen, P., E. J. Baron, D. M. Citron, C. A. Strong, H. M. Wexler, and S. M. Finegold. 1993. Wadsworth anaerobic bacteriology manual, 5th ed. Star Publishing Co., Belmont, Calif.
33. Tuner, K., L. Lindqvist, and C. E. Nord. 1985. Purification and properties of a novel β-lactamase from Fusobacterium nucleatum. Antimicrob Agents Chemother 27:943-947.
34. Vohr, H.-W., G. Wasinska-Kempka, and H. J. Ahr. 1996. Studies on the phototoxic potential of a new 8-methoxy-quinolone: Bay 12-8039, abstr. F-21, p. 103. In Program and abstracts of the 36th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
35. Woodcock, J. M., J. M. Andrews, F. J. Boswell, N. P. Brenwald, and R. Wise. 1997. In vitro activity of Bay 12-8039, a new fluoroquinolone. Antimicrob. Agents Chemother. 41:101-106.